0001415889-23-004192.txt : 20230303
0001415889-23-004192.hdr.sgml : 20230303
20230303180020
ACCESSION NUMBER: 0001415889-23-004192
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NOYES TIMOTHY P
CENTRAL INDEX KEY: 0001185035
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40544
FILM NUMBER: 23706365
MAIL ADDRESS:
STREET 1: 1365 MAIN STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc.
CENTRAL INDEX KEY: 0001798749
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831377888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 930 WINTER STREET
STREET 2: SUITE M-500
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-443-2400
MAIL ADDRESS:
STREET 1: 930 WINTER STREET
STREET 2: SUITE M-500
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4-03032023_060301.xml
X0306
4
2023-03-01
0001798749
Aerovate Therapeutics, Inc.
AVTE
0001185035
NOYES TIMOTHY P
C/O AEROVATE THERAPEUTICS, INC.
930 WINTER STREET, SUITE M-500
WALTHAM
MA
02451
true
true
false
false
CHIEF EXECUTIVE OFFICER
Common Stock
2023-03-01
4
M
0
15000
2.14
A
15000
D
Common Stock
2023-03-01
4
S
0
5962
22.7071
D
9038
D
Common Stock
2023-03-01
4
S
0
2672
23.8109
D
6366
D
Common Stock
2023-03-01
4
S
0
5316
24.6878
D
1050
D
Common Stock
2023-03-01
4
S
0
1050
25.67
D
0
D
Stock Option (Right to Buy)
2.14
2023-03-01
4
M
0
15000
0
D
2031-04-01
Common Stock
15000
433381
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.25 to $23.24, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.31 to $24.20, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.33 to $25.06, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.
/s/ George A. Eldridge, Attorney-in-Fact
2023-03-03